InsightfulValue
← Home

Roche
Roche

Pharma / Pharmaceuticals and Healthcare


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Roche

πŸ“Š Get full analytics about Roche

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

Price
Live  
Infographic
Infographics
Overview
Roche is a Swiss multinational healthcare company that operates globally, with its headquarters in Basel, Switzerland. The company was founded in 1896 by Fritz Hoffmann-La Roche and is today one of the largest pharmaceutical companies in the world, with a focus on developing and manufacturing innovative medicines and diagnostics for improving people's health and quality of life.
Roche is divided into two main divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division focuses on developing drugs and therapies for a wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. The Diagnostics division specializes in providing diagnostic solutions for early detection, prevention, diagnosis, and management of diseases.
In addition to its core areas of pharmaceuticals and diagnostics, Roche also has a strong presence in the fields of oncology, neurology, immunology, and virology. The company's portfolio includes well-known brands such as Avastin, Herceptin, Rituxan, and Tamiflu.
Roche has a global workforce of over 98,000 employees, with operations in more than 100 countries. The company invests heavily in research and development, with over 16 billion Swiss francs invested in 2020 alone.
Roche is committed to sustainability and social responsibility, taking into account environmental, social, and economic aspects in all of its operations. The company has received numerous awards and recognition for its initiatives in these areas, including being named as one of the world's most sustainable companies by the Dow Jones Sustainability Indices.
In addition to its focus on healthcare, Roche is also involved in various philanthropic and humanitarian efforts, such as providing access to healthcare for underserved communities, supporting education and research, and investing in sustainable healthcare infrastructure in developing countries.
How to explain to a 10 year old kid about the company?
Roche

πŸ“ˆ Want to read more about Roche?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Um9jaGUgaX MgYSBiaWcg Y29tcGFueS B0aGF0IHdv cmtzIGluIG hlYWx0aCBh bmQgbWVkaW NpbmUuIFRo ZXkgY3JlYX RlIGltcG9y dGFudCB0b2 9scyBhbmQg bWVkaWNpbm VzIHRoYXQg aGVscCBkb2 N0b3JzIGFu ZCBob3NwaX RhbHMgdGFr ZSBjYXJlIG 9mIHNpY2sg cGVvcGxlLi BJbWFnaW5l IGlmIHNvbW VvbmUgaGFz IGEgYmFkIG NvbGQgb3Ig c29tZXRoaW 5nIG1vcmUg c2VyaW91cy BsaWtlIGNh bmNlci4gUm 9jaGUgbWFr ZXMgdGVzdH MgdG8gZmln dXJlIG91dC B3aGF0IGlz IHdyb25nLC BhbmQgdGhl eSBhbHNvIG 1ha2UgbWVk aWNpbmVzIH RvIGhlbHAg cGVvcGxlIG ZlZWwgYmV0 dGVyLjxicj 5Sb2NoZSBt YWtlcyBtb2 5leSBieSBz ZWxsaW5nIH RoZXNlIHRl c3RzIGFuZC BtZWRpY2lu ZXMuIFdoZW 4gZG9jdG9y cyBuZWVkIH RvIGZpbmQg b3V0IHdoYX QgaXMgbWFr aW5nIHNvbW VvbmUgc2lj aywgdGhleS BidXkgdGhl IHRlc3RzIG Zyb20gUm9j aGUsIGFuZC B3aGVuIHRo ZXkgbmVlZC B0byB0cmVh dCBwYXRpZW 50cywgdGhl eSBvcmRlci B0aGUgbWVk aWNpbmVzLi BCZWNhdXNl IHRoZXkgaG VscCBzYXZl IGxpdmVzIG FuZCBtYWtl IHBlb3BsZS BoZWFsdGhp ZXIsIG1hbn kgaG9zcGl0 YWxzIGFuZC Bkb2N0b3Jz IHRydXN0IG FuZCBjaG9v c2UgUm9jaG XigJlzIHBy b2R1Y3RzLj xicj5Sb2No ZSBpcyBzdW NjZXNzZnVs IGZvciBhIG ZldyByZWFz b25zLiBGaX JzdCwgdGhl eSBpbnZlc3 QgYSBsb3Qg b2YgdGltZS BhbmQgbW9u ZXkgaW50by ByZXNlYXJj aCB0byBmaW 5kIG5ldyB3 YXlzIHRvIH RyZWF0IGRp c2Vhc2VzLC BtYWtpbmcg dGhlbSBhIG xlYWRlciBp biBzY2llbm NlIGFuZCBt ZWRpY2luZS 4gVGhleSBh bHNvIHdvcm sgd2l0aCBz Y2llbnRpc3 RzIGFuZCBy ZXNlYXJjaG VycyB0byBr ZWVwIGNvbW luZyB1cCB3 aXRoIGJldH RlciB0cmVh dG1lbnRzLi BTZWNvbmQs IHRoZXkgbW FrZSBzdXJl IHRoZWlyIH Byb2R1Y3Rz IGFyZSB2ZX J5IGhpZ2gg cXVhbGl0eS wgd2hpY2gg bWVhbnMgZG 9jdG9ycyBh bmQgaG9zcG l0YWxzIGNh biByZWx5IG 9uIHRoZW0u IExhc3RseS wgbWFueSBw ZW9wbGUgYX JlIGdldHRp bmcgb2xkZX IgYW5kIHRo ZXJlIGFyZS BuZXcgZGlz ZWFzZXMsIH NvIHRoZSBu ZWVkIGZvci BuZXcgbWVk aWNpbmVzIG FuZCB0ZXN0 cyBpcyBncm 93aW5nLiBS b2NoZSBpcy ByZWFkeSB0 byBtZWV0IH RoaXMgZGVt YW5kLCB3aG ljaCBoZWxw cyB0aGVtIG NvbnRpbnVl IHRvIGJlIH N1Y2Nlc3Nm dWwgaW4gdG hlIGZ1dHVy ZS48YnI+
What is special about the company?
Roche

πŸ“ˆ Want to read more about Roche?

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

MS4gUGlvbm VlcmluZyBI ZWFsdGhjYX JlIElubm92 YXRpb25zOi BSb2NoZSBo YXMgYSBsb2 5nIGhpc3Rv cnkgb2YgcG lvbmVlcmlu ZyBicmVha3 Rocm91Z2gg dHJlYXRtZW 50cyBmb3Ig ZGlzZWFzZX MgbGlrZSBj YW5jZXIsIG 11bHRpcGxl IHNjbGVyb3 NpcywgYW5k IEhJVi9BSU RTLiBUaGUg Y29tcGFueS BoYXMgYWxz byBiZWVuIG F0IHRoZSBm b3JlZnJvbn Qgb2YgZGV2 ZWxvcGluZy BkaWFnbm9z dGljIHRlc3 RzIGFuZCBw ZXJzb25hbG l6ZWQgbWVk aWNpbmUgdG 8gaW1wcm92 ZSBwYXRpZW 50IG91dGNv bWVzLjxicj 4yLiBHbG9i YWwgUHJlc2 VuY2U6IFJv Y2hlIGlzIG EgdHJ1bHkg aW50ZXJuYX Rpb25hbCBj b21wYW55LC B3aXRoIGEg cHJlc2VuY2 UgaW4gb3Zl ciAxMDAgY2 91bnRyaWVz IHdvcmxkd2 lkZS4gSXQg aXMgY29uc2 lzdGVudGx5 IHJhbmtlZC BhcyBvbmUg b2YgdGhlIH RvcCBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMgaW 4gdGhlIHdv cmxkIGFuZC BoYXMgYSBz dHJvbmcgcH Jlc2VuY2Ug aW4gYm90aC BkZXZlbG9w ZWQgYW5kIG VtZXJnaW5n IG1hcmtldH MuPGJyPjMu IFN0cm9uZy BSZXNlYXJj aCBhbmQgRG V2ZWxvcG1l bnQ6IFJvY2 hlIGludmVz dHMgaGVhdm lseSBpbiBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn QsIHdpdGgg YSBmb2N1cy BvbiB0cmFu c2xhdGluZy BzY2llbnRp ZmljIGRpc2 NvdmVyaWVz IGludG8gaW 5ub3ZhdGl2 ZSB0cmVhdG 1lbnRzIGFu ZCBkaWFnbm 9zdGljIHRv b2xzLiBJbi AyMDE5LCB0 aGUgY29tcG FueSBpbnZl c3RlZCBvdm VyIDExIGJp bGxpb24gU3 dpc3MgZnJh bmNzIChhcH Byb3hpbWF0 ZWx5ICQxMS 4zIGJpbGxp b24gVVNEKS BpbiBSJkQu PGJyPjQuIE NvbW1pdG1l bnQgdG8gU3 VzdGFpbmFi aWxpdHk6IF JvY2hlIGlz IGNvbW1pdH RlZCB0byBz dXN0YWluYW JsZSBidXNp bmVzcyBwcm FjdGljZXMg YW5kIGhhcy BzZXQgYW1i aXRpb3VzIG dvYWxzIHRv IHJlZHVjZS BpdHMgZW52 aXJvbm1lbn RhbCBpbXBh Y3QgYW5kIH Byb21vdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Li BUaGUgY29t cGFueSBoYX MgYmVlbiBy ZWNvZ25pem VkIGZvciBp dHMgZWZmb3 J0cyBpbiBz dXN0YWluYW JpbGl0eSwg aW5jbHVkaW 5nIGJlaW5n IG5hbWVkIG 9uZSBvZiB0 aGUgd29ybG QncyBtb3N0 IHN1c3RhaW 5hYmxlIGNv bXBhbmllcy BieSB0aGUg RG93IEpvbm VzIFN1c3Rh aW5hYmlsaX R5IEluZGlj ZXMuPGJyPj UuIENvbGxh Ym9yYXRpdm UgUGFydG5l cnNoaXBzOi BSb2NoZSB2 YWx1ZXMgcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX Bhbmllcywg YWNhZGVtaW MgaW5zdGl0 dXRpb25zLC BhbmQgaGVh bHRoY2FyZS Bvcmdhbml6 YXRpb25zLi BUaGlzIGFw cHJvYWNoIG FsbG93cyB0 aGUgY29tcG FueSB0byBh Y2Nlc3Mgbm V3IHRlY2hu b2xvZ2llcy BhbmQgZXhw ZXJ0aXNlIG FuZCBhY2Nl bGVyYXRlIH RoZSBkZXZl bG9wbWVudC BvZiBpbm5v dmF0aXZlIH RyZWF0bWVu dHMuPGJyPj YuIFN0cm9u ZyBQb3J0Zm 9saW8gb2Yg UHJvZHVjdH M6IFJvY2hl IGhhcyBhIG RpdmVyc2Ug cG9ydGZvbG lvIG9mIHBy b2R1Y3RzLC BpbmNsdWRp bmcgYmlvbG 9naWMgYW5k IHNtYWxsIG 1vbGVjdWxl IG1lZGljaW 5lcywgZGlh Z25vc3RpYy B0ZXN0cywg YW5kIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBz ZXJ2aWNlcy 4gVGhpcyBh bGxvd3MgdG hlIGNvbXBh bnkgdG8gc2 VydmUgYSB3 aWRlIHJhbm dlIG9mIGRp c2Vhc2UgYX JlYXMgYW5k IHBhdGllbn QgcG9wdWxh dGlvbnMuPG JyPjcuIENv bW1pdG1lbn QgdG8gRXRo aWNzIGFuZC BDb21wbGlh bmNlOiBSb2 NoZSBoYXMg YSBzdHJvbm cgY29tbWl0 bWVudCB0by BldGhpY2Fs IGJ1c2luZX NzIHByYWN0 aWNlcyBhbm QgY29tcGxp YW5jZSB3aX RoIGxhd3Mg YW5kIHJlZ3 VsYXRpb25z LiBUaGUgY2 9tcGFueSBo YXMgYSBjb2 1wcmVoZW5z aXZlIGNvZG Ugb2YgY29u ZHVjdCBhbm QgdHJhaW5z IGFsbCBlbX Bsb3llZXMg b24gZXRoaW NhbCBzdGFu ZGFyZHMgYW 5kIGNvbXBs aWFuY2UgcG 9saWNpZXMu PGJyPjguIE VtcGhhc2lz IG9uIEVtcG xveWVlIERl dmVsb3BtZW 50OiBSb2No ZSByZWNvZ2 5pemVzIHRo ZSBpbXBvcn RhbmNlIG9m IGludmVzdG luZyBpbiBp dHMgZW1wbG 95ZWVzIGFu ZCBmb3N0ZX JpbmcgYSBj dWx0dXJlIG 9mIGlubm92 YXRpb24sIG RpdmVyc2l0 eSwgYW5kIG luY2x1c2lv bi4gVGhlIG NvbXBhbnkg b2ZmZXJzIG EgdmFyaWV0 eSBvZiB0cm FpbmluZyBh bmQgZGV2ZW xvcG1lbnQg cHJvZ3JhbX MgYW5kIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBudW1lcm 91cyBjb3Vu dHJpZXMuPG JyPjkuIFBh dGllbnQtQ2 VudHJpYyBB cHByb2FjaD ogUm9jaGUg cHV0cyBwYX RpZW50cyBh dCB0aGUgY2 VudGVyIG9m IGV2ZXJ5dG hpbmcgdGhl eSBkbyBhbm Qgd29ya3Mg Y2xvc2VseS B3aXRoIGhl YWx0aGNhcm UgcHJvdmlk ZXJzIGFuZC BwYXRpZW50 IG9yZ2FuaX phdGlvbnMg dG8gZW5zdX JlIHRoYXQg dGhlaXIgdH JlYXRtZW50 cyBhbmQgc2 VydmljZXMg bWVldCB0aG UgbmVlZHMg b2YgcGF0aW VudHMuPGJy PjEwLiBMb2 5nLVRlcm0g VmlzaW9uOi BSb2NoZSBo YXMgYSBsb2 5nLXRlcm0g dmlzaW9uIG ZvciBzdXN0 YWluYWJsZS Bncm93dGgg YW5kIGlzIG NvbW1pdHRl ZCB0byBtYW tpbmcgYSBw b3NpdGl2ZS BpbXBhY3Qg b24gc29jaW V0eS4gVGhl IGNvbXBhbn kncyBtaXNz aW9uLCAiRG 9pbmcgbm93 IHdoYXQgcG F0aWVudHMg bmVlZCBuZX h0LCIgcmVm bGVjdHMgaX RzIGRlZGlj YXRpb24gdG 8gY29uc3Rh bnRseSBwdX NoaW5nIHRo ZSBib3VuZG FyaWVzIG9m IGhlYWx0aG NhcmUgdG8g aW1wcm92ZS BwYXRpZW50 IG91dGNvbW VzLg==
What the company's business model?
Roche

πŸ“ˆ Want to read more about Roche?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

VGhlIFJvY2 hlIGNvbXBh bnkgaXMgYS BnbG9iYWwg aGVhbHRoY2 FyZSBjb21w YW55IHRoYX QgZm9jdXNl cyBvbiBwaG FybWFjZXV0 aWNhbHMgYW 5kIGRpYWdu b3N0aWNzLi BUaGVpciBi dXNpbmVzcy Btb2RlbCBp cyB0byBkZX ZlbG9wLCBt YW51ZmFjdH VyZSwgYW5k IG1hcmtldC Bpbm5vdmF0 aXZlIG1lZG ljaW5lcyBh bmQgZGlhZ2 5vc3RpYyB0 ZXN0cyB0aG F0IGNhbiBo ZWxwIHBhdG llbnRzIGJl dHRlciBtYW 5hZ2UgYW5k IHRyZWF0IG Egd2lkZSBy YW5nZSBvZi BkaXNlYXNl cyBhbmQgbW VkaWNhbCBj b25kaXRpb2 5zLjxicj5S b2NoZSdzIG J1c2luZXNz IG1vZGVsIG lzIGJ1aWx0 IGFyb3VuZC B0aGVpciBj b21taXRtZW 50IHRvIHJl c2VhcmNoIG FuZCBkZXZl bG9wbWVudC wgd2l0aCBz aWduaWZpY2 FudCBpbnZl c3RtZW50cy BpbiBib3Ro IGZpZWxkcy 4gVGhlIGNv bXBhbnkgaG FzIGEgZGl2 ZXJzZSBwb3 J0Zm9saW8g b2YgcHJvZH VjdHMgdGhh dCBpbmNsdW RlcyBwcmVz Y3JpcHRpb2 4gbWVkaWNp bmVzLCBkaW Fnbm9zdGlj IHRlc3RzLC BhbmQgc29s dXRpb25zIG ZvciBwZXJz b25hbGl6ZW QgaGVhbHRo Y2FyZS48Yn I+Um9jaGUn cyBrZXkgc3 RyYXRlZ2ll cyBpbmNsdW RlIGZvY3Vz aW5nIG9uIG FyZWFzIG9m IGhpZ2ggdW 5tZXQgbWVk aWNhbCBuZW VkLCBjb2xs YWJvcmF0aW 5nIHdpdGgg ZXh0ZXJuYW wgcGFydG5l cnMgdG8gbG V2ZXJhZ2Ug dGhlaXIgZX hwZXJ0aXNl LCBhbmQgaW 52ZXN0aW5n IGluIHRoZS BkZXZlbG9w bWVudCBvZi BuZXcgYW5k IHByb21pc2 luZyB0ZWNo bm9sb2dpZX MuPGJyPklu IGFkZGl0aW 9uLCBSb2No ZSBoYXMgYS BzdHJvbmcg cHJlc2VuY2 UgaW4gZW1l cmdpbmcgbW Fya2V0cywg bWFraW5nIH RoZWlyIHBy b2R1Y3RzIG FjY2Vzc2li bGUgdG8gYS BsYXJnZXIg cG9wdWxhdG lvbi4gVGhl IGNvbXBhbn kgYWxzbyBw cmlvcml0aX plcyBzdXN0 YWluYWJpbG l0eSBhbmQg Y29ycG9yYX RlIHJlc3Bv bnNpYmlsaX R5LCBhaW1p bmcgdG8gbW FrZSBhIHBv c2l0aXZlIG ltcGFjdCBv biBzb2NpZX R5Ljxicj5P dmVyYWxsLC BSb2NoZSdz IGJ1c2luZX NzIG1vZGVs IGlzIGRyaX ZlbiBieSB0 aGVpciBtaX NzaW9uIHRv IGltcHJvdm UgdGhlIGxp dmVzIG9mIH BhdGllbnRz IHdvcmxkd2 lkZSB0aHJv dWdoIHRoZW lyIGlubm92 YXRpdmUgaG VhbHRoY2Fy ZSBzb2x1dG lvbnMu
Is AI a threat?
AI does have the potential to pose a material threat to Roche’s products, services, and competitive positioning in several ways.
1. Substitution: AI can enhance or replace certain diagnostic and therapeutic processes. For example, AI algorithms are increasingly being used in diagnostics to interpret imaging results or analyze genetic data, which could compete with Roche’s existing products in personalized medicine and diagnostics. If other companies develop AI-driven solutions that provide faster or more accurate results, Roche could face challenges in maintaining its market share.
2. Disintermediation: AI technologies can enable direct-to-consumer models, allowing patients to access personalized health insights and treatments without going through traditional healthcare providers or pharmaceutical companies. This could disrupt Roche’s traditional business model, particularly in diagnostics and therapeutic services where intermediaries play a significant role.
3. Margin Pressure: The integration of AI in healthcare can lead to increased competition, as new entrants might use AI to reduce operational costs and improve efficiency. As a result, Roche could face price pressure on its products and services. Companies leveraging AI may be able to offer similar solutions at lower prices, making it more challenging for Roche to maintain its profit margins.
Overall, while AI holds the potential to enhance healthcare, it also introduces vulnerabilities for Roche that could impact its competitive positioning and profitability in various markets. Roche will need to adapt and innovate to leverage AI effectively, while also addressing the competitive threats it presents.
Sensitivity to interest rates
The sensitivity of Roche’s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Earnings Sensitivity: Roche, as a pharmaceutical company, generates revenue primarily from the sale of drugs and diagnostics. While its sales might not be directly affected by interest rates, the company’s earnings could be impacted by the cost of capital. If interest rates rise, financing costs increase, potentially reducing profit margins, especially if the company relies on debt to fund operations or R&D.
2. Cash Flow Sensitivity: Roche’s cash flow is influenced by operational performance and capital structure. Higher interest rates can lead to increased interest expenses on existing debt, which can constrain cash flow available for reinvestment or dividends. Moreover, if higher rates slow economic growth, it could affect revenue-generating activities, further impacting cash flow.
3. Valuation Sensitivity: Valuation models, such as discounted cash flow (DCF), are sensitive to changes in interest rates. A rising interest rate environment typically leads to a higher discount rate applied to future cash flows, which can result in lower present values and, consequently, a lower valuation for Roche. Investors often adjust their required rates of return based on prevailing interest rates, which can further influence Roche’s stock price.
In summary, while Roche’s core operations may not be directly tied to interest rate fluctuations, the broader financial implicationsβ€”such as costs of capital, cash flow dynamics, and valuation methodsβ€”can make the company’s financial performance somewhat sensitive to interest rate changes. An increase in rates can lead to higher costs, reduced cash flow, and a downward pressure on valuation. Conversely, lower interest rates could provide a beneficial environment for earnings growth, cash flow expansion, and improved valuations.
Resilience to the future changes
Roche

πŸ“ˆ Want to read more about Roche?

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgUm 9jaGXigJlz IGVjb25vbW ljcyBvdmVy IHRoZSBuZX h0IDPigJM1 IHllYXJzIG lzIHRoZSBs b3NzIG9mIH BhdGVudCBw cm90ZWN0aW 9uIG9uIGtl eSBibG9ja2 J1c3RlciBk cnVncywgY2 9tYmluZWQg d2l0aCBhIH NpZ25pZmlj YW50IGluY3 JlYXNlIGlu IGNvbXBldG l0aW9uIGZy b20gYmlvc2 ltaWxhcnMg YW5kIGdlbm VyaWNzLiA8 YnI+SWYgUm 9jaGXigJlz IGZsYWdzaG lwIHByb2R1 Y3RzLCBsaW tlIGl0cyBj YW5jZXIgbW VkaWNhdGlv bnMgYW5kIG 90aGVyIHNw ZWNpYWx0eS BwaGFybWFj ZXV0aWNhbH MsIHdlcmUg dG8gbG9zZS BwYXRlbnQg ZXhjbHVzaX ZpdHksIGl0 IGNvdWxkIH Jlc3VsdCBp biBhIHN1Yn N0YW50aWFs IGRlY2xpbm UgaW4gcmV2 ZW51ZS4gVG hlIGVudHJ5 IG9mIGJpb3 NpbWlsYXJz IGFuZCBnZW 5lcmljcyB0 eXBpY2FsbH kgbGVhZHMg dG8gcHJpY2 UgZXJvc2lv biwgd2hpY2 ggd291bGQg ZnVydGhlci BleGFjZXJi YXRlIHRoZS BkZWNsaW5l IGluIHNhbG VzIGZvciBS b2NoZeKAmX MgZXhpc3Rp bmcgZHJ1Zy Bwb3J0Zm9s aW8uIEZvci BleGFtcGxl LCBpZiBhIG 1ham9yIGNh bmNlciB0cm VhdG1lbnQg ZHJ1ZyBleH BlcmllbmNl cyBhIDUwJS ByZWR1Y3Rp b24gaW4gc2 FsZXMgdm9s dW1lIGR1ZS B0byBuZXcg bWFya2V0IG VudHJhbnRz LCBSb2NoZS BtaWdodCBz ZWUgYSBkcm FtYXRpYyBk cm9wIGluIG l0cyBvdmVy YWxsIHJldm VudWUuPGJy PlRoZSBjb2 1wYW554oCZ cyBtYXJnaW 5zIHdvdWxk IGJlZ2luIH RvIHNocmlu ayBzaWduaW ZpY2FudGx5 IGFzIGEgcm VzdWx0IG9m IHRoaXMgcm V2ZW51ZSBk ZWNsaW5lLi BXaXRoIHRo ZSBsb3dlci BzYWxlcyBw cmljZXMgdG hhdCBjb21l IHdpdGggaW 5jcmVhc2Vk IGNvbXBldG l0aW9uLCBS b2NoZeKAmX MgZ3Jvc3Mg bWFyZ2lucy Bjb3VsZCBk aXAgYmVsb3 cgaW5kdXN0 cnkgc3Rhbm RhcmRzLCBw b3RlbnRpYW xseSBmYWxs aW5nIGZyb2 0gdGhlIGN1 cnJlbnQgNz AlLTgwJSBy YW5nZSB0by Bhcm91bmQg NTAlLTYwJS 4gQWRkaXRp b25hbGx5LC BmaXhlZCBj b3N0cyBmb3 IgcmVzZWFy Y2ggYW5kIG RldmVsb3Bt ZW50LCBtYX JrZXRpbmcs IGFuZCBhZG 1pbmlzdHJh dGl2ZSBleH BlbnNlcyB3 b3VsZCBjb2 50aW51ZSB0 byBleGVydC BwcmVzc3Vy ZSBvbiB0aG UgY29tcGFu eSwgY2F1c2 luZyBvcGVy YXRpbmcgbW FyZ2lucyB0 byBkZWNsaW 5lIGV2ZW4g ZnVydGhlci 48YnI+Q2Fz aCBmbG93IH dvdWxkIGJl IG5lZ2F0aX ZlbHkgYWZm ZWN0ZWQgYX Mgd2VsbC4g V2l0aCByZW R1Y2VkIHJl dmVudWVzLC BSb2NoZeKA mXMgZnJlZS BjYXNoIGZs b3csIHdoaW NoIGlzIGNy dWNpYWwgZm 9yIGZ1bmRp bmcgb25nb2 luZyByZXNl YXJjaCBhbm QgcmV0dXJu aW5nIHZhbH VlIHRvIHNo YXJlaG9sZG VycywgbWln aHQgZGVjcm Vhc2Ugc2hh cnBseS4gVG hlIGNvbXBh bnkgbWF5IH N0cnVnZ2xl IHRvIG1haW 50YWluIGl0 cyBoaXN0b3 JpY2FsIGxl dmVscyBvZi BkaXZpZGVu ZCBwYXlvdX RzIGFuZCBz dG9jayBidX liYWNrcywg bGVhZGluZy B0byBkZWNy ZWFzZWQgaW 52ZXN0b3Ig Y29uZmlkZW 5jZS48YnI+ TGFzdGx5LC BSb2NoZeKA mXMgYmFsYW 5jZSBzaGVl dCBjb3VsZC BkZXRlcmlv cmF0ZSB1bm RlciB0aGlz IHNjZW5hcm lvLiBJZiBj YXNoIGZsb3 cgZGVjbGlu ZXMgYW5kIH RoZSBjb21w YW554oCZcy BhYmlsaXR5 IHRvIGludm VzdCBpbiBu ZXcgZHJ1Z3 MgZGltaW5p c2hlcywgUm 9jaGUgbWln aHQgbmVlZC B0byByZXNv cnQgdG8gZG VidCBmaW5h bmNpbmcgdG 8gc3RhYmls aXplIGl0cy BvcGVyYXRp b25zLiBUaG lzIGNvdWxk IGxlYWQgdG 8gYW4gaW5j cmVhc2UgaW 4gdGhlIGRl YnQtdG8tZX F1aXR5IHJh dGlvLCBhZH ZlcnNlbHkg aW1wYWN0aW 5nIHRoZSBj b21wYW554o CZcyBjcmVk aXQgcmF0aW 5nLiBJZiBk ZWJ0IGxldm VscyByaXNl IHRvbyBoaW doIHdpdGhv dXQgY29ycm VzcG9uZGlu ZyByZXZlbn VlIHRvIHN1 cHBvcnQgaW 50ZXJlc3Qg cGF5bWVudH MsIFJvY2hl IGNvdWxkIG ZpbmQgaXRz ZWxmIGluIG EgcHJlY2Fy aW91cyBwb3 NpdGlvbiwg bGVhZGluZy B0byBwb3Rl bnRpYWwgbG lxdWlkaXR5 IGlzc3Vlcy 48YnI+SW4g c3VtbWFyeS wgdGhpcyBz Y2VuYXJpby B3b3VsZCBs aWtlbHkgcm VzdWx0IGlu IHNpZ25pZm ljYW50bHkg bG93ZXIgcm V2ZW51ZSBh bmQgcHJvZm l0IG1hcmdp bnMsIHJlZH VjZWQgY2Fz aCBmbG93IG FmZmVjdGlu ZyBvcGVyYX Rpb25hbCBm bGV4aWJpbG l0eSwgYW5k IGEgc3RyYW luZWQgYmFs YW5jZSBzaG VldCwgZWFj aCBjb250cm lidXRpbmcg dG8gYSBsb2 5nLXRlcm0g ZGVjbGluZS BpbiBSb2No ZeKAmXMgZW Nvbm9taWMg aGVhbHRoLj xicj4=
Interesting facts about the company
Roche

πŸ“ˆ Want to read more about Roche?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvV0 96enhFcGNt R2Q4UXlha2 JzNUsud2Vi cCIgYWx0PS JSb2NoZSIg dGl0bGU9Il JvY2hlIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTUwIHdp ZHRoPTUwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IF JvY2hlPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg4p qhIEluc3Rh bnRseSBhY2 Nlc3MgPGk+ IlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3MiPC9pPi DigJQgZnJl ZSEKICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxMn B4OyBmb250 LXNpemU6ID EzcHg7IGNv bG9yOiAjND Q0Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIG5vdy BhbmQgZ2V0 IG91ciBmcm VlIGVCb29r IAogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGI+VGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrczwvYj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDE2cHg7 IGZvbnQtc2 l6ZTogMTRw eDsgY29sb3 I6ICM0NDQ7 IGZvbnQtZm FtaWx5OiAt YXBwbGUtc3 lzdGVtLCBC bGlua01hY1 N5c3RlbUZv bnQsIFNlZ2 9lIFVJLCBS b2JvdG8sIE hlbHZldGlj YSBOZXVlLC BzYW5zLXNl cmlmOyBsaW 5lLWhlaWdo dDogMS42Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BIYXZlIHlv dSBoZWFyZC BhYm91dCBv dXIgc2hvcn QgPHN0cm9u ZyBzdHlsZT 0nZm9udC13 ZWlnaHQ6ID YwMDsnPkRh aWx5IFZpZG VvIE5ld3Ns ZXR0ZXI8L3 N0cm9uZz4/ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dodHRwczov L3d3dy5pbn NpZ2h0ZnVs dmFsdWUuY2 9tL25ld3Ns ZXR0ZXIucG hwJyB0YXJn ZXQ9J19ibG Fuaycgc3R5 bGU9J2NvbG 9yOiAjMDA3 QkZGOyB0ZX h0LWRlY29y YXRpb246IG 5vbmU7IGZv bnQtd2VpZ2 h0OiA1MDA7 IG1hcmdpbi 1sZWZ0OiA2 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BGaW5kIG91 dCBtb3JlCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 E+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg CiAgICAgIC AgCiAgICAg ICAgPHNwYW 4gY2xhc3M9 J2JsdXJyZW QtdGV4dCc+ CiAgICAgIC AgICAgIE1T NGdSbTkxYm 0gUmxaQ0Jw YmlBeCBPRG sySUdKNUlF IFp5YVhSNk lFaHYgWm1a dFlXNXVMVS B4aElGSnZZ MmhsIExDQl NiMk5vWlMg QnBjeUJoSU ZOMyBhWE56 SUcxMWJIIF JwYm1GMGFX OXUgWVd3Z2 FHVmhiSCBS b1kyRnlaU0 JqIGIyMXdZ VzU1SUggUm 9ZWFFnYjNC bCBjbUYwWl hNZ2FXIDRn YjNabGNpQX ggTURBZ1ky OTFibiBSeW FXVnpJSGR2 IGNteGtkMm xrWlMgNDhZ bkkrTWk0Zy BVbTlqYUdV Z2FYIE1nZE dobElIZHYg Y214azRvQ1 pjeSBCc1lY Sm5aWE4wIE lHSnBiM1Js WTIgZ2dZMj l0Y0dGdSBl U0JoYm1RZ2 FYIE1nWVNC c1pXRmsgWl hJZ2FXNGdk RyBobElHWn BaV3hrIElH OW1JSEJsY2 4gTnZibUZz YVhwbCBaQ0 JvWldGc2RH IGhqWVhKbE xDQjMgYUds amFDQm1iMi BOMWMyVnpJ Rzl1IElHUm xkbVZzYjMg QnBibWNnZE dGcCBiRzl5 WldRZ2RIIE psWVhSdFpX NTAgY3lCbW IzSWdjRyBG MGFXVnVkSE 1nIFltRnpa V1FnYjIgNG dkR2hsYVhJ ZyBhVzVrYV hacFpIIFZo YkNCblpXNW wgZEdsaklH MWhhMiBWMW NDNDhZbkkr IE15NGdVbT lqYUcgVWdh R0Z6SUdFZy BhR2x6ZEc5 eWVTIEJ2Wm lCa1pYWmwg Ykc5d2FXNW 5JRyBkeWIz VnVaR0p5IF pXRnJhVzVu SUcgMWxaR2 xqYVc1bCBj eUJoYm1RZ1 pHIGxoWjI1 dmMzUnAgWT NNc0lHbHVZ MiB4MVpHbH VaeUIwIGFH VWdabWx5Yz MgUWdZVzUw YVdKcCBiM1 JwWXlBb2NH IFZ1YVdOcG JHeHAgYmlr c0lIUm9aUy BCbWFYSnpk Q0JoIGJuUn BjbVYwY20g OTJhWEpoYk NCMCBjbVZo ZEcxbGJuIF FnWm05eUlF aEogVmk5Ql NVUlRMQyBC aGJtUWdkR2 hsIElHWnBj bk4wSUggUn laV0YwYldW dSBkQ0JtYj NJZ2FHIFZ3 WVhScGRHbH ogSUVNdVBH SnlQaiBRdU lGUm9aU0Jq IGIyMXdZVz U1SUcgbHVk bVZ6ZEhNZy BhR1ZoZG1s c2VTIEJwYm lCeVpYTmwg WVhKamFDQm hibSBRZ1pH VjJaV3h2IG NHMWxiblFz SUggZHBkR2 dnYjNabCBj aUFrTVRJZ1 ltIGxzYkds dmJpQnogY0 dWdWRDQnBi aSBBeU1ESX dJR0ZzIGIy NWxMaUJKZE MgQmhiSE52 SUhCaCBjbl J1WlhKeklI IGRwZEdnZ1 lTQjMgYVdS bElISmhibS BkbElHOW1J R0ZqIFlXUm xiV2xqSUcg bHVjM1JwZE hWMCBhVzl1 Y3lCaGJtIF FnWW1sdmRH VmogYUNCam IyMXdZVyA1 cFpYTWdkRz hnIFlXUjJZ VzVqWlMgQm 9aV0ZzZEdo aiBZWEpsSU dsdWJtIDky WVhScGIyNH UgUEdKeVBq VXVJRiBKdl kyaGxJR2ho IGN5QmhJR1 JwZG0gVnlj MlVnY0c5eS BkR1p2Ykds dklHIDltSU hCeWIyUjEg WTNSekxDQn BibSBOc2RX UnBibWNnIF ltOTBhQ0J3 Y20gVnpZM0 pwY0hScCBi MjRnWkhKMV ozIE1nWVc1 a0lHUnAgWV dkdWIzTjBh VyBNZ2RHVn pkSE11IElF bDBjeUJ0WV cgbHVJR0Z5 WldGeiBJRz ltSUdadlkz IFZ6SUdsdV kyeDEgWkdV Z2IyNWpiMi B4dloza3NJ R2x0IGJYVn ViMnh2WjMg a3NJR0Z1Wk NCdSBaWFZ5 YjNOamFXIF Z1WTJVdVBH SnkgUGpZdU lGUm9aUyBC amIyMXdZVz U1IElIQnNZ V05sY3kgQm hJSE4wY205 dSBaeUJsYl hCb1lYIE5w Y3lCdmJpQn ogZFhOMFlX bHVZVyBKcG JHbDBlU0Jo IGJtUWdhR0 Z6SUggTmxk Q0JoYldKcC BkR2x2ZFhN Z1oyIDloYk hNZ2RHOGcg Y21Wa2RXTm xJRyBsMGN5 QmxiblpwIG NtOXViV1Z1 ZEcgRnNJR2 x0Y0dGaiBk Q0JoYm1RZ2 FXIDVqY21W aGMyVWcgWV dOalpYTnpJ SCBSdklHaG xZV3gwIGFH TmhjbVVnYV cgNGdkVzVr WlhKeiBaWE oyWldRZ1ky IDl0YlhWdW FYUnAgWlhN dVBHSnlQai BjdUlGSnZZ MmhsIElHaG hjeUJoSUgg TnBaMjVwWm 1saiBZVzUw SUhCeVpYIE 5sYm1ObElH bHUgSUhSb1 pTQlZibSBs MFpXUWdVM1 JoIGRHVnpM Q0IzYVggUm 9JR2wwY3lC TyBiM0owYU NCQmJXIFZ5 YVdOaGJpQm 8gWldGa2NY VmhjbiBSbG NuTWdiRzlq IFlYUmxaQ0 JwYmkgQkpi bVJwWVc1aC BjRzlzYVhN c0lFIGx1Wk dsaGJtRXUg UEdKeVBqZ3 VJRSBsdUlE SXdNVGtzIE lGSnZZMmhs SUggSmhibX RsWkNCaCBj eUIwYUdVZ0 5IIFJvSUcx dmMzUWcgYz NWemRHRnBi bSBGaWJHVW dZMjl0IGNH RnVlU0JwYm kgQjBhR1Vn ZDI5eSBiR1 FnWW5rZ1Ey IDl5Y0c5eV lYUmwgSUV0 dWFXZG9kSC BNdVBHSnlQ amt1IElGUm 9aU0JqYjIg MXdZVzU1NG 9DWiBjeUJ6 ZVcxaWIyIH dzSUhSb1pT Qm8gWlhoaF oyOXVZVyB3 Z1VtOWphR1 VnIGJHOW5i eXdnY20gVn djbVZ6Wlc1 MCBjeUIwYU dVZ2MyIGw0 SUdOb1pXMX AgWTJGc0lH VnNaVyAxbG JuUnpJR1Z6 IGMyVnVkR2 xoYkMgQm1i M0lnYkdsbS BaVG9nWTJG eVltIDl1TE NCb2VXUnkg YjJkbGJpd2 dibSBsMGNt OW5aVzRzIE lHOTRlV2Rs Ymkgd2djR2 h2YzNCbyBi M0oxY3l3Z1 lXIDVrSUhO MWJHWjEgY2 k0OFluSStN VCBBdUlGSn ZZMmhsIElH bHpJR052Yl cgMXBkSFJs WkNCMCBieU JrYVhabGNu IE5wZEhrZ1 lXNWsgSUds dVkyeDFjMi BsdmJpd2dk MmwwIGFDQm hJSGR2Y20g dG1iM0pqWl NCMCBhR0Yw SUdsdVkyIH gxWkdWeklH VnQgY0d4dm VXVmxjeSBC bWNtOXRJRz kyIFpYSWdN VFV3SUcgUn BabVpsY21W dSBkQ0J1WV hScGIyIDVo YkdsMGFXVn ogSUdGdVpD QmhJRyBkdl lXd2dkRzhn IFlXTm9hV1 YyWlMgQm5a VzVrWlhJZy BZbUZzWVc1 alpTIEJwYm lCc1pXRmsg WlhKemFHbH dJSCBCdmMy bDBhVzl1IG N5ND0KICAg ICAgICA8L3 NwYW4+CiAg ICAgICAgCi AgICAgICAg
See Company Q&A
Roche

πŸ“Š Get full analytics about Roche

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal